Maternal hypertension and neurodevelopmental outcome in very preterm infants

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 79, Issue 2, 1998, Pages

  Gray, Peter H ^a   O'Callaghan, Michael J ^a   Mohay, Heather A ^a   Burns, Yvonne R ^a   King, James F ^a  

^a MATER HOSPITAL   (Australia)

Author keywords

Cerebral palsy; Maternal hypertension; Neurodevelopment; Pre eclampsia

Indexed keywords

ANTIHYPERTENSIVE AGENT; MAGNESIUM SULFATE; PHENYTOIN;

ARTICLE; BRAIN DEVELOPMENT; CEREBRAL PALSY; CONTROLLED STUDY; CONVULSION; HUMAN; INFANT; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; NEWBORN; PREMATURITY; PRIORITY JOURNAL;

EID: 0031690106     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/fn.79.2.F88     Document Type: Article

References (35)

1. McCowan LAIE, Buist RG, North RA, Gamble G. Perinatal morbidity in chronic hypertension. Br J Obstet Gynaccol 1996;103:123-9.
2. Brown MA, Buddle ML. Hypertension in pregnancy-: maternal and fetal outcome according to laboratory and clinical features. Med J Amt 1996;165:360-5.
3. Hagberg G, Hagberg B, Olow I. The changing panorama of cerebral palsy in Sweden 1954 - 70. III. The importance of foetal deprivation of supply. Acta Paedriatrica Scand 1976;65:403-8.
4. Jonas O, Stern LM, Macharper T. A South Australian study of pregnancy and birth risk factors associated with cerebral palsy. Im JRehabil Res 1989;12:159-66.
5. Murphy DJ, Sellers S, MacKenzie IZ, Yudkin PL, Johnson AM. Case-control study of antenatal and intraparrum risk factors for cerebral palsy in very preterm singleton babies. Lanîl995;346:1449-54.
6. Grether JK, Nelson KB, Emery ES, Cummins SK. Prenatal and perinatal factors and cerebral palsy in very low birth weight infants. J Ptdiatr 1996;128:407-14.
7. Nelson KB, Grether JK. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics 1995;95:263-9.
8. Szymonowicz \V, Yu VYH. Severe pre-eclampsia and infants of very low birth weight. Arch Dis Child 1987;62:712-6.
9. Spinillo A, lasci A, Capuzzo, E, Egbe TO, Colona L, Fazzi E. Two-year neurodevelopmental outcome after expectant management and indicated preterm delivery in hypertensive pregnancies. Acta Obstet Gynecol Scand 1994;73:6259.
10. Korkman M, Hilakivi-Clarke LA, Autti-Ramo I, Fellman V, Grandstrom M-L. Cognitive impairments at two years of age after prenatal alcohol exposure or perinatal asphyxia. Neuropediatrics 1994;25:101-5.
11. Van Zeban der Aa DM, Verwey RA, Verloove-Vanhorick SP, Brand R, Ruys JH. Maternal hypertension and very preterm infants mortality and handicaps. Eur J Obsict fynccol Reprod Biol 1986;23:137-44.
12. Australasian Society for the Study of Hypertension in Pregnancy. Management of hypertension in pregnancy: executive summary. McdJAust 1993;158:700-2.
13. Kitchen WH, Robinson HP, Dickinson AJ. Revised intrauterine growth curves for an Australian population. AmtPaediatrJ 1983;19:157-61.
14. Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirements in the neonatal period. Pediatrics 1988;82:527-32.
15. Tudehope DI, Masel J, Mohay H, et al. Neonatal cranial ultrasonography as predictor of 2 year outcome of very low birthweight infants. Aust PaediatrJ 1989;25:66-11.
16. Bax MCO. Terminology and classification of cerebral palsy. DevMed Child AVwro/1964;6:295-307.
17. Burns YR. NSMDA. Physiotherapy assessment for infants and young children. Brisbane: Copyright Publishing Company, 1992.
18. O'Callaghan MJ, Burns Y, Gray P, et al. Extremely low birth and control infants at 2 years corrected age: a comparison of intellectual abilities, motor performance, growth and health. Early Hum Dcv 1995;40:115-25.
19. Griffiths R. The ability of young children. London: Child Development Research Centre, 1970.
20. APA. Diagnostic and Statistical Manual of Menial Disorders. 3rd edn (revised). Washington, DC: American Psychiatric Association, 1987:22-3.
21. Harms K, Rath \V, Herting E, Kühn W. Maternal hemolysis, elevated liver enzymes, low platelet count and neonatal outcome. Am J Perinatal 1995;12:1-6.
22. Derham RJ, Hawkins DF, de Vries LS, Aber VR. Outcome of pregnancies complicated by severe hypertension and delivered before 34 weeks; stepwise logistic regression analysis of prognostic factors. Br J Obstet Gynaecol 1989;96:1173-81.
23. Catanzarite V, Quirk JG, Aisenbrey G. How do perinatologists manage preeclampsia?/îm J Périnatal 1991;S:7-10.
24. Banias BB, Devoe LD, Nolan TE. Severe preeclampsia in preterm pregnancy between 26 and 32 weeks' gestation. AmJPerinatol 1992;9:357-60.
25. Tubman TRJ, Rollins MD, Patterson C, Halliday HL. Increased incidence of respiratory distress syndrome in babies of hypertensive mothers. Arch Dis Child 1991;66:52-4.
26. Kuban KCK, Leviton A, Pagano M, Fenton T, Strassfcld R, WohT Al. Maternal toxaemia is associated with reduced incidence of germinal matrix hemorrhage in premature babies. J Child Neural 1992;7:70-6.
27. Shankaran S, Baeur CR, Bain R, Wright LL, Zachary J. Prenatal and perinatal risk and protective factors for neonatal intracranial hemorrhage. Arch Pediatr Adolesc Med 1996:150:491-7.
28. Nelson KB, Ellenberg JH. Antecedents of cerebral palsy I. Univariate analysis of risks. Am J Dis Child 1985;139:1031-8.
29. Palmer L, Blair E, Petterson B, Burton P. Antenatal antecedents of moderate and severe cerebral palsy. Paediatr Perinat Epidemiol 1995;9:171-84.
30. Rogers B, Msall M, Owens T, et al. Cystic periventricular leukomalacia and type of cerebral palsy in preterm infants. J Pediatr 1994;l2S:Sl-8.
31. Murphy DJ, Squier MV, Hope PL, Sellers S, Johnson A. Clinical associations and time of onset of cerebral white matter damage in very preterm babies. Arch Dis Child 1996;7S:F27-F32.
32. Ounsted MK, Moar VA, Good FJ. Hypertension during pregnancy with and without specific treatment; the development of the children at four years. BrJ Obstet Gynaecol 1980;87:19-24.
33. Taylor DJ, Howie PW, Davidson J, Davidson D, Drillien CM. Do pregnancy complications contribute to neurodevelopmental disability? Lancet 1985;i:713-6.
34. Martikainen A. Growth and development at the age of 1.5 years in children with maternal hypertension. J Perinat Med\989;ll:259-69.
35. Schendel DE, Berg CJ, Yeargin-Allsopp M, Boyle CA, Decourle P. Prenatal magnesium sulfate exposure and the risk for cerebral palsy and mental retardation among very low-birth-weight children aged 3 to 5 years. JAMA 1996;276:1805-10.